| Primary |
| Parkinson's Disease |
45.0% |
| Restless Legs Syndrome |
10.8% |
| Hypertension |
8.3% |
| Depression |
5.0% |
| Parkinsonism |
3.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.3% |
| Epilepsy |
2.5% |
| Extrapyramidal Disorder |
2.5% |
| Insomnia |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Atrial Fibrillation |
1.7% |
| Cardiac Failure |
1.7% |
| Diabetes Mellitus |
1.7% |
| Hepatic Cirrhosis |
1.7% |
| Hypothyroidism |
1.7% |
| Medical Diet |
1.7% |
| Prophylaxis |
1.7% |
| Analgesic Therapy |
0.8% |
| Anxiety |
0.8% |
| Benign Prostatic Hyperplasia |
0.8% |
|
| Somnolence |
9.4% |
| Sudden Onset Of Sleep |
9.4% |
| Weight Decreased |
9.4% |
| Hallucinations, Mixed |
6.3% |
| Liver Function Test Abnormal |
6.3% |
| Pancreatitis Acute |
6.3% |
| Product Substitution Issue |
6.3% |
| Sopor |
6.3% |
| Vomiting |
6.3% |
| Acute Psychosis |
3.1% |
| Blood Glucose Increased |
3.1% |
| Drug Ineffective |
3.1% |
| Drug Interaction |
3.1% |
| Hallucination |
3.1% |
| Hemiparesis |
3.1% |
| Hepatic Encephalopathy |
3.1% |
| Incontinence |
3.1% |
| Intestinal Resection |
3.1% |
| Malabsorption |
3.1% |
| Medication Error |
3.1% |
|
| Secondary |
| Parkinson's Disease |
46.9% |
| Depression |
12.5% |
| Prophylaxis |
4.7% |
| Analgesic Therapy |
3.1% |
| Bipolar Disorder |
3.1% |
| Erectile Dysfunction |
3.1% |
| Medical Diet |
3.1% |
| Parkinsonism |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Restless Legs Syndrome |
3.1% |
| Hypertension |
2.3% |
| Benign Prostatic Hyperplasia |
1.6% |
| Dementia |
1.6% |
| Extrapyramidal Disorder |
1.6% |
| Hepatic Cirrhosis |
1.6% |
| Insomnia |
1.6% |
| Pain |
1.6% |
| Contraception |
0.8% |
| Hypothyroidism |
0.8% |
| Nausea |
0.8% |
|
| Sopor |
20.0% |
| Pathological Gambling |
11.4% |
| Visual Impairment |
11.4% |
| Drug Interaction |
5.7% |
| Hyperhidrosis |
5.7% |
| Malabsorption |
5.7% |
| Parkinson's Disease |
5.7% |
| Pulmonary Hypertension |
5.7% |
| Sudden Onset Of Sleep |
5.7% |
| Acute Psychosis |
2.9% |
| Hepatic Encephalopathy |
2.9% |
| Impulse-control Disorder |
2.9% |
| Restlessness |
2.9% |
| Sluggishness |
2.9% |
| Tremor |
2.9% |
| Vomiting |
2.9% |
| Weight Decreased |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.0% |
| Parkinson's Disease |
23.2% |
| Hypertension |
5.9% |
| Non-hodgkin's Lymphoma |
4.2% |
| Vomiting |
3.8% |
| B-cell Lymphoma |
3.4% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Depression |
3.4% |
| Osteoporosis |
3.4% |
| Hallucination |
2.5% |
| Nausea |
2.5% |
| Acute Myeloid Leukaemia |
2.1% |
| Benign Prostatic Hyperplasia |
2.1% |
| Dementia Alzheimer's Type |
2.1% |
| Multiple Myeloma |
2.1% |
| Restless Legs Syndrome |
2.1% |
| Colon Cancer |
1.7% |
| Coronary Arterial Stent Insertion |
1.7% |
| Diabetes Mellitus |
1.7% |
| Epilepsy |
1.7% |
|
| Sopor |
9.3% |
| Syncope |
9.3% |
| Parkinson's Disease |
7.0% |
| Vertigo |
7.0% |
| Acute Myocardial Infarction |
4.7% |
| Blood Creatine Phosphokinase Increased |
4.7% |
| Convulsion |
4.7% |
| Inflammatory Bowel Disease |
4.7% |
| Injection Site Ulcer |
4.7% |
| Loss Of Consciousness |
4.7% |
| Lower Respiratory Tract Infection |
4.7% |
| Medication Residue |
4.7% |
| Muscular Weakness |
4.7% |
| Nausea |
4.7% |
| Neuroleptic Malignant Syndrome |
4.7% |
| Paralysis |
4.7% |
| Rash |
4.7% |
| Angioedema |
2.3% |
| Breast Cancer |
2.3% |
| Cholestasis |
2.3% |
|
| Interacting |
| Parkinson's Disease |
57.1% |
| Depression |
14.3% |
| Essential Hypertension |
14.3% |
| Benign Prostatic Hyperplasia |
7.1% |
| Myocardial Ischaemia |
7.1% |
|
| Gastrointestinal Haemorrhage |
50.0% |
| Depressed Level Of Consciousness |
16.7% |
| Psychotic Disorder |
16.7% |
| Syncope |
16.7% |
|
